Antonio Aversa
Antonio Aversa is an expert in Endocrinology at Magna Graecia University (Italy). As of October 2026, ScienceLeadR ranks Antonio Aversa in the top 1% of experts worldwide for Erectile Dysfunction, Sexual Dysfunctions, Psychological and Sexual Dysfunction, Physiological. Antonio Aversa has authored 352 publications, the most recent in 2026, and is an investigator in 3 clinical trials, 1 of them ongoing. SLR score: 1,040 (community average: 125). How the SLR is computed.
LeadR Profile
Endocrinology
Subspecialties: Biochemistry - Genetics - Urology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Short Biography
Antonio Aversa, MD, PhD: Biosketch
Current Position & Clinical Roles
Dr. Antonio Aversa is a Full Professor of Endocrinology at the University of Catanzaro Magna Graecia, within the Department of Experimental and Clinical Medicine. He serves as the Director of both the School of Specialization in Endocrinology and Metabolic Disease and the Master's degree course in "Clinical Andrology". Furthermore, he is a teaching professor of Endocrinology for several specialization schools and coordinates the outpatient Andrology unit at the Renato Dulbecco University Hospital.
Education & Professional Training
- Medical Degree: Earned his Master's degree in Medicine and Surgery (summa cum laude) from the University of Rome "La Sapienza".
- Post-Academic Studies: Completed specializations in Endocrinology, Metabolic Diseases, and Andrology; earned a PhD in Andrological Sciences; and obtained a Master's degree in Research Enhancement and Development (RED) at the University of Rome "La Sapienza".
- International Training: Undertook a stage abroad at the Department of Andrology at the University of California San Francisco (UCSF) in 1994.
Scientific Output & Leadership
- Publications & Awards: He has authored more than 260 international scientific papers and dedicated books in reproductive and geriatric medicine, and he received the Award of Excellence from the ESSM Scientific Committee in Lisbon in 2007.
- Societies: He serves as the regional President of the Italian Society for Human Reproduction, is the former Secretary General of SIAMS, and is the founder/coordinator of specialized study groups including Club SIE "Geriatric Endocrinology".
- Editorial Roles: He actively serves as an Associate Editor, board member, guest editor, and reviewer for numerous prominent medical journals.
Organizations
Career arc: 1996 - 2026
Number : 352
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Reversible azoospermia associated with the selective JAK1 inhibitor abrocitinib: a case report. PMID 42554763 — azoospermia, safety, genetics, reproductive techniques, recycling, fertilization in vitro, hormones, embryo transfer, therapeutics, spermatogenesis, spermatozoa | J Assist Reprod Genet | 2026 | 0 |
| Response to comment on: penile prosthesis implantation for patients with comorbid severe premature ejaculation and erectile dysfunction: a pilot cohort study. PMID 42493581 — premature ejaculation, prosthesis implantation, pilots, erectile dysfunction, penile prosthesis, cohort studies, ejaculation, penile implantation | Int J Impot Res | 2026 | 0 |
| Penile Rehabilitation After Surgery for Prostate Cancer: An Umbrella Review on Traditional Approaches and Novel Perspectives. PMID 42355856 — phosphodiesterase 5 inhibitors, erectile dysfunction, microscopy, electron, scanning transmission, penile prosthesis, regenerative medicine, neoplasms, prostate, rehabilitation, prostatic neoplasms, therapeutics, prostatectomy | J Clin Med | 2026 | 1 |
| Effect of breastfeeding on cardiometabolic risk in patients with polycystic ovary syndrome. PMID 42329360 — diabetes mellitus, endocrinology, diabetes, gestational, hypertension, pregnancy, ovary, breast feeding, polycystic ovary syndrome | J Endocrinol Invest | 2026 | 0 |
| Mid-pregnancy serum chemerin levels predict persistence of postpartum hypertension in patients with polycystic ovary syndrome. PMID 42299478 — hypertension, pregnancy, serum, ovary, predictive value of tests, hormones, polycystic ovary syndrome, adipokines, postpartum period | Eur J Endocrinol | 2026 | 1 |
Clinical Studies 3
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Open label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy NCT06484868 — safety, leptin, lipodystrophy, multiple chronic conditions, diet, therapeutics | Phase 4 | Recruiting | 2024 |
LeadR Networks
Main global connection map